Literature DB >> 29436441

Sepsis - thoughtful management for the non-expert.

Robert Tidswell1, Mervyn Singer1.   

Abstract

Sepsis is a common and often devastating medical emergency with a high mortality rate and, in many survivors, long-term morbidity. It is defined as the dysregulated host response to infection resulting in organ dysfunction, and its incidence is increasing as the population ages. However, it is a treatable and potentially reversible condition, especially if identified and treated promptly. A sound understanding of sepsis is crucial for optimal care. Although general guidelines are available for management, here we provide a foundation of understanding to encourage thoughtful, personalised management of sepsis during the acute phase. We provide an overview of the epidemiology, the new Sepsis-3 definitions, pathophysiology, clinical presentations, and investigation and management of sepsis for the non-expert. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  acute medicine; infection; intensive care medicine; medical education; sepsis; septic shock

Mesh:

Year:  2018        PMID: 29436441      PMCID: PMC6330922          DOI: 10.7861/clinmedicine.18-1-62

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  20 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Authors:  Jens U Jensen; Lars Hein; Bettina Lundgren; Morten H Bestle; Thomas T Mohr; Mads H Andersen; Klaus J Thornberg; Jesper Løken; Morten Steensen; Zoe Fox; Hamid Tousi; Peter Søe-Jensen; Anne Ø Lauritsen; Ditte Strange; Pernille L Petersen; Nanna Reiter; Søren Hestad; Katrin Thormar; Paul Fjeldborg; Kim M Larsen; Niels E Drenck; Christian Ostergaard; Jesper Kjær; Jesper Grarup; Jens D Lundgren
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

4.  Predictors of long-term mortality after severe sepsis in the elderly.

Authors:  Allyson C Lemay; Antonio Anzueto; Marcos I Restrepo; Eric M Mortensen
Journal:  Am J Med Sci       Date:  2014-04       Impact factor: 2.378

Review 5.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12

Review 6.  Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.

Authors:  D Harrison; H Muskett; S Harvey; R Grieve; J Shahin; K Patel; Z Sadique; E Allen; R Dybowski; M Jit; J Edgeworth; C Kibbler; R Barnes; N Soni; K Rowan
Journal:  Health Technol Assess       Date:  2013-02       Impact factor: 4.014

7.  Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013.

Authors:  Vincenzo De Santis; Mihaela Gresoiu; Alberto Corona; A Peter R Wilson; Mervyn Singer
Journal:  J Antimicrob Chemother       Date:  2014-09-03       Impact factor: 5.790

Review 8.  Sepsis: pathophysiology and clinical management.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  BMJ       Date:  2016-05-23

9.  Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study.

Authors:  Peter M C Klein Klouwenberg; Olaf L Cremer; Lonneke A van Vught; David S Y Ong; Jos F Frencken; Marcus J Schultz; Marc J Bonten; Tom van der Poll
Journal:  Crit Care       Date:  2015-09-07       Impact factor: 9.097

10.  Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.

Authors:  Frank Bloos; Daniel Thomas-Rüddel; Hendrik Rüddel; Christoph Engel; Daniel Schwarzkopf; John C Marshall; Stephan Harbarth; Philipp Simon; Reimer Riessen; Didier Keh; Karin Dey; Manfred Weiß; Susanne Toussaint; Dirk Schädler; Andreas Weyland; Maximillian Ragaller; Konrad Schwarzkopf; Jürgen Eiche; Gerhard Kuhnle; Heike Hoyer; Christiane Hartog; Udo Kaisers; Konrad Reinhart
Journal:  Crit Care       Date:  2014-03-03       Impact factor: 9.097

View more
  4 in total

1.  Which crystalloid? Does fluid choice influence patient outcomes in sepsis?

Authors:  Sam Roberts
Journal:  Clin Med (Lond)       Date:  2018-06       Impact factor: 2.659

2.  Effect of procalcitonin on the severity and prognostic value of elderly patients with a severe infection of oral and maxillofacial space.

Authors:  Xin-Yan Lin; Yu-Zhao Lin; Shao-Hua Lin; Jun-Jie Lian
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

3.  The Long Pentraxin PTX3 Controls Klebsiella Pneumoniae Severe Infection.

Authors:  Fatemeh Asgari; Domenico Supino; Raffaella Parente; Nadia Polentarutti; Matteo Stravalaci; Remi Porte; Fabio Pasqualini; Marialuisa Barbagallo; Chiara Perucchini; Camilla Recordati; Elena Magrini; Andrea Mariancini; Federica Riva; Alessia Giordano; Sadaf Davoudian; Thierry Roger; Cornelis Van't Veer; Sebastien Jaillon; Alberto Mantovani; Andrea Doni; Cecilia Garlanda
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

4.  Toddalolactone Protects Lipopolysaccharide-Induced Sepsis and Attenuates Lipopolysaccharide-Induced Inflammatory Response by Modulating HMGB1-NF-κB Translocation.

Authors:  Jingyu Ni; Yuxuan Zhao; Jing Su; Zhihao Liu; Shiming Fang; Lan Li; Jie Deng; Guanwei Fan
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.